Exponent (NASDAQ:EXPO) Price Target Cut to $80.00 by Analysts at JPMorgan Chase & Co.

Posted by Francis Steltz on May 15th, 2026

Exponent (NASDAQ:EXPO – Get Free Report) had its price target reduced by equities researchers at JPMorgan Chase & Co. from $95.00 to $80.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an “overweight” rating on the business services provider’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 47.18% from the stock’s previous close.

EXPO has been the topic of several other research reports. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research note on Tuesday, April 21st. UBS Group dropped their price target on shares of Exponent from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Exponent has an average rating of “Moderate Buy” and an average price target of $77.50.

Read Our Latest Analysis on Exponent

Exponent Stock Performance

Shares of EXPO stock traded up $0.69 during trading hours on Friday, hitting $54.36. 141,576 shares of the company were exchanged, compared to its average volume of 472,177. Exponent has a one year low of $51.91 and a one year high of $81.95. The business’s 50-day simple moving average is $66.10 and its two-hundred day simple moving average is $69.85. The stock has a market capitalization of $2.64 billion, a price-to-earnings ratio of 25.28 and a beta of 0.78.

Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The business services provider reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.03. The firm had revenue of $166.30 million for the quarter, compared to analyst estimates of $149.53 million. Exponent had a net margin of 18.07% and a return on equity of 27.94%. Exponent’s quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.52 earnings per share. As a group, analysts anticipate that Exponent will post 2.28 EPS for the current fiscal year.

Insider Buying and Selling

In other Exponent news, VP Joseph Sala sold 2,066 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $56.66, for a total value of $117,059.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Catherine Corrigan sold 3,920 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00. Following the completion of the sale, the chief executive officer owned 93,731 shares of the company’s stock, valued at approximately $6,294,036.65. The trade was a 4.01% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 16,752 shares of company stock valued at $1,069,921. Company insiders own 1.60% of the company’s stock.

Institutional Trading of Exponent

Hedge funds and other institutional investors have recently bought and sold shares of the stock. United Services Automobile Association acquired a new stake in shares of Exponent during the 1st quarter valued at about $270,000. Jane Street Group LLC boosted its position in shares of Exponent by 1,481.0% during the 1st quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider’s stock valued at $10,313,000 after acquiring an additional 119,175 shares in the last quarter. Invesco Ltd. boosted its position in shares of Exponent by 3.3% during the 2nd quarter. Invesco Ltd. now owns 554,733 shares of the business services provider’s stock valued at $41,444,000 after acquiring an additional 17,930 shares in the last quarter. First Trust Advisors LP acquired a new stake in shares of Exponent during the 2nd quarter valued at about $18,377,000. Finally, Walleye Capital LLC boosted its position in shares of Exponent by 7.5% during the 2nd quarter. Walleye Capital LLC now owns 6,623 shares of the business services provider’s stock valued at $495,000 after acquiring an additional 464 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

About Exponent

(Get Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.